NEW YORK (GenomeWeb News) — Wafergen BioSystems said today it has landed $1.3 million in a private placement of common stock.
 
Wafergen last week said it had gained $10.7 million in financing as it completed a reverse merger with a shell company.
  
The company said last week it plans to use the proceeds from the investment for corporate infrastructure and product offerings, such as the company’s SmartChip system.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.